Shanghai Bao Pharmaceuticals Co LtdHKEX: 2659

2026 Interim report

· Issued by Shanghai Bao Pharmaceuticals Co Ltd via HKEXnews

Filed with HKEX · Stock code 2659 · · 81 pages · English

Summary by 6ix AI

Additionally, it discusses collaborations with other pharmaceutical companies to enhance product development and market access strategies. The report also includes corporate governance information and the composition of the board of directors.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Shanghai Bao Pharmaceuticals Co Ltd on 6ix

Earlier from Shanghai Bao Pharmaceuticals

Later from Shanghai Bao Pharmaceuticals

All Shanghai Bao Pharmaceuticals news releases